• 1
    Epstein JI. Incidence and significance of positive margins in radical prostatectomy specimens. Urol Clin North Am 1996; 23: 65163
  • 2
    Alkhateeb S, Alibhai S, Fleshner N et al. Impact of positive surgical margins after radical prostatectomy differs by disease risk group. J Urol 2010; 183: 14550
  • 3
    Eastham JA, Kattan MW, Riedel E et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 2003; 170 (6 Pt 1): 22925
  • 4
    Chun FK, Briganti A, Antebi E et al. Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in european patients. BJU Int 2006; 98: 12049
  • 5
    Marcovich R, Wojno KJ, Wei JT, Rubin MA, Montie JE, Sanda MG. Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer. Urology 2000; 55: 9048
  • 6
    Karakiewicz PI, Eastham JA, Graefen M et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology 2005; 66: 124550
  • 7
    Pettus JA, Weight CJ, Thompson CJ, Middleton RG, Stephenson RA. Biochemical failure in men following radical retropubic prostatectomy: impact of surgical margin status and location. J Urol 2004; 172: 12932
  • 8
    Stephenson AJ, Scardino PT, Eastham JA et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005; 23: 700512
  • 9
    Blute ML, Bostwick DG, Bergstralh EJ et al. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology 1997; 50: 7339
  • 10
    Khan MA, Partin AW, Mangold LA, Epstein JI, Walsh PC. Probability of biochemical recurrence by analysis of pathologic stage, gleason score, and margin status for localized prostate cancer. Urology 2003; 62: 86671
  • 11
    Freedland SJ, Humphreys EB, Mangold LA et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005; 294: 4339
  • 12
    Schaeffer EM, Partin AW, Lepor H et al. Radical retropubic and perineal prostaectomy. In Wein AJ, Kavoussi LR, Novick AC et al. eds, Vol. 3, ch. 102, Campbell-Walsh Urology, 10th edn. Philadelphia: Elsevier Inc., 2012: 280129
  • 13
    Boorjian SA, Karnes RJ, Crispen PL et al. The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. J Urol 2010; 183: 10039
  • 14
    Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 15917
  • 15
    Jhaveri FM, Zippe CD, Klein EA, Kupelian PA. Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results. Urology 1999; 54: 88490
  • 16
    Sehdev AE, Pan CC, Epstein JI. Comparative analysis of sampling methods for grossing radical prostatectomy specimens performed for nonpalpable (stage T1c) prostatic adenocarcinoma. Hum Pathol 2001; 32: 4949
  • 17
    Evans AJ, Henry PC, Van der Kwast TH et al. Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens. Am J Surg Pathol 2008; 32: 150312
  • 18
    Garcia JJ, Al-Ahmadie HA, Gopalan A et al. Do prostatic transition zone tumors have a distinct morphology? Am J Surg Pathol 2008; 32: 170914
  • 19
    Fleshner NE, Evans A, Chadwick K, Lawrentschuk N, Zlotta A. Clinical significance of the positive surgical margin based upon location, grade, and stage. Urol Oncol 2010; 28: 197204
  • 20
    Eggener SE, Scardino PT, Walsh PC et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 2011; 185: 86975
  • 21
    Eastham JA, Kattan MW, Riedel E et al. Variations among individual surgeons in the rate of positive surigal margins in radical prostatectomy specimens. J Urol 2003; 170 (6 Pt 1): 22925
  • 22
    Van der Kwast TH, Bolla M, Van Poppel H et al. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol 2007; 25: 417886
  • 23
    Wright JL, Dalkin BL, True LD et al. Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. J Urol 2010; 183: 22138
  • 24
    Porter CR, Kodama K, Gibbons RP, Correa R Jr, Chun FK, Perrotte P. Karakiewicz et al. 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. J Urol 2006; 176: 56974
  • 25
    Sofer M, Hamilton-Nelson KL, Civantos F, Soloway MS. Positive surgical margins after radical retropubic prostatectomy: the influence of site and number on progression. J Urol 2002; 167: 24536
  • 26
    van Oort IM, Bruins HM, Kiemeney LA, Knipscheer BC, Witjes JA, Hulsbergen-van de Kaa CA. The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomy. Histopathology 2010; 56: 46471
  • 27
    Resnick MJ, Canter DJ, Guzzo TJ et al. Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiotherapy. BJU Int 2010; 105: 137780
  • 28
    Cao D, Kibel AS, Gao F, Tao Y, Humphrey PA. The Gleason score of tumor at the margin in radical prostatectomy is predictive of biochemical recurrence. Am J Surg Pathol 2010; 34: 9941001
  • 29
    Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy. J Urol 2008; 179: 135460